INTRODUCTION
============

Many studies have reported that the inflammation is an important causative factor for cardiovascular disease (CVD)^[@b1-kjim-19-2-99-5],\ [@b2-kjim-19-2-99-5])^, and the serum markers in inflammatory reaction, including C-reactive protein, fibrinogen and von Willebrand factor, are associated with CVD^[@b3-kjim-19-2-99-5]--[@b5-kjim-19-2-99-5])^. In acute coronary syndrome, the peripheral leukocytes increase due to the adrenocortical reaction, via the hypothalamus-hypophysis-adrenal axis and sympathetic activation. Such increases in leukocytes are known to as markers in acute inflammatory reactions and a poor short-term prognostic indicator in acute coronary syndrome^[@b6-kjim-19-2-99-5],\ [@b7-kjim-19-2-99-5])^. Stable angina is known to be related with low-grade systemic inflammation^[@b8-kjim-19-2-99-5],\ [@b9-kjim-19-2-99-5])^. It has also been reported that the systemic T-cells^[@b10-kjim-19-2-99-5])^, proinflammatory cytokines and neutrophils are activated in stable angina^[@b11-kjim-19-2-99-5])^. Even though peripheral leukocytes in a condition with no acute stress have been reported to be associated with other cardiovascular risk factors, as a non-specific marker for chronic inflammation^[@b12-kjim-19-2-99-5],\ [@b13-kjim-19-2-99-5])^ and risk factor and long-term prognostic factor for CVD^[@b14-kjim-19-2-99-5]--[@b17-kjim-19-2-99-5])^, there have been few studies on the correlation between peripheral leukocytes and the severity of CVD. Thus, the this study was conducted on patients who had taken coronary angiography for the confirmative diagnosis of stable angina to clarify whether the peripheral leukocyte count is a risk factor for stable angina and associated with disease progression.

MATERIALS AND METHODS
=====================

1. Patients
-----------

This cross-sectional study was performed on 200 patients (96 males and 104 females) who had been hospitalized under suspicion of angina pectoris. Informed consent was obtained from each patient, and the study protocol, in accordance to the Declaration of Helsinki, was approved by the institutional committee on human research. Patients with myocardial infarction at admission (total creatine kinase\>2×N and increased CK-MB isoenzyme mass during the first 24 hours), myocardial infarction within the previous 2 months, unstable angina (angina at rest, recent onset, or crescendo angina within 4 weeks) and a known infectious or inflammatory disease were excluded. The severity of stable angina was evaluated on the basis of the Gensini's score^[@b18-kjim-19-2-99-5])^. Patients with Gensini's scores of 0 and over 1 were allocated to the control (92 patients: 45 males and 47 females) and stable angina group (108 patients: 51 males and 57 females), respectively. A comparison of the baseline clinical characteristics and peripheral leukocyte count was conducted. For the patients in the stable angina group, the correlation between peripheral leukocyte count and Gensini's score was analyzed.

2. Physical examination and blood test
--------------------------------------

The mean blood pressure, after measuring 3 times in supine position, was selected and body mass index (kg/m^2^) calculated. Blood tests were performed with blood sampled from the antecubital vein prior to coronary angiography. The peripheral leukocyte count was measured with by automated hemocytometry (XE-2100, Sysmex, Japanese). The total cholesterol and triglyceride were measured with enzymatic calorimetric tests, high density lipoprotein (HDL) with a selective inhibition method and low density lipoprotein (LDL) with a homogeneous enzymatic calorimetric test. Hypertensive patients were defined as those with a past hypertension history, those with anti-hypertensive medication or those with a systolic pressure over 140 mmHg or a diastolic pressure over 90 mmHg on an outpatient visit. Diabetic patients were defined as those with a past diabetic history insulin or oral hypoglycemic medication and those with a fasting blood sugar over 126 mg/dL or a postprandial 2-h blood sugar over 200 mg/dL.

3. Coronary angiography
-----------------------

Coronary angiography was performed with Judkins technique. A cardiac catheter was percutaneously inserted into the femoral artery, and contrast medium injected into the left/right coronary artery to obtain the anterior view, left anterior oblique 60 degree's view and right anterior oblique 60 degree's view for interpretation by a cardiology specialist. To evaluate the degree of coronary stenosis with the Digital Vascular Imaging System (Integris H3000, Philips, Netherlands), the minimum percentile lumen of stenotic lesions to the vascular lumen of normal lesions was obtained. Stenosis of over 25% resulted in referral to the Gensini's score.

4. Statistical Analysis
-----------------------

All the data was statistically analyzed using the SPSS program (Version 10.0, Inc., Chicago, IL) for MS Windows. The Gensini's scores were log transformed to normalize the data for analysis. For each group, the mean value was analyzed with the Student's *t*-test. Associations between 2 categorical variables were tested by the Chi-squared test. Multivariate analysis was performed on the findings of the univariate analysis. For an intra-group analysis on the CVD group for correlation between the peripheral leukocyte count and Gensini's score, the Spearman's correlation coefficient was used. A value of *p*\<0.05 was determined to be significant.

RESULTS
=======

The mean patient age was 59.8±10.8 years, and the mean peripheral leukocyte count and 50 percentile were 6974±1,850/mm^3^ and 6,800/mm^3^, respectively. There was no significant difference in the peripheral leukocyte count between smokers and non-smokers. The mean Gensini's score in the stable angina group was 23.2±28. The peripheral leukocyte count was 7,300±1,500/mm^3^ in the stable angina group, which was significantly higher than the 6,500±1,500/mm^3^ in the control group (*p*\<0.01). Age, the prevalence of hypertension and diabetes, and the fasting blood sugar were significantly higher and the HDL cholesterol lower in the stable angina than the control group ([Table 1](#t1-kjim-19-2-99-5){ref-type="table"}).

In the univariate analysis, the odds ratio of the patients with a peripheral leukocyte count at the 50 percentile level over 6,800/mm^3^ was 1.79 (95% C.I: 1.02--3.16). The odds ratio of the patients over 45 years in males and over 55 years in females was 3.15 (95% C.I: 1.48--6.68). The odds ratio of the hypertensive and diabetic patients to that of the normal patients were 2.64 (95% C.I: 1.49--4.68) and 4.50 (95% C.I: 2.15--9.44), respectively. Logistic multiple regression analysis on the independent variables, such as significant risk factors from the univariate analysis (peripheral leukocyte count, age, hypertension and diabetes), showed that a peripheral leukocyte count over 6,800/mm^3^ was an independent variable, but with no statistical significance (*p*=0.067), and that diabetes (OR=3.02, 95% CI: 1.29--7.02) and old age (OR=3.62, 95% CI: 1.33--9.87) were independent risk factors for CVD ([Table 2](#t2-kjim-19-2-99-5){ref-type="table"}).

The variables significantly correlated with Gensini's score were the peripheral leukocyte count and fasting blood sugar (*p*=0.028 and 0.001 respectively)([Table 3](#t3-kjim-19-2-99-5){ref-type="table"}). The analysis of the correlation between peripheral leukocyte count and Gensini's score in stable angina group showed that there was a positive correlation, even after adjusting for age, fasting blood sugar, blood pressure and lipid profiles (R^2^=0.198 and *p*=0.015)([Figure 1](#f1-kjim-19-2-99-5){ref-type="fig"}).

DISCUSSION
==========

Even though most studies on the correlation between peripheral leukocytes and CVD have been performed in the field of epidemiology, none have presented consistent results. Gillum et al.^[@b19-kjim-19-2-99-5])^ stated that the peripheral leukocytes are not an independent cardiovascular risk factor but a mediator and indicator of smoking. In a study on patients who had undergone coronary angiography, Kostis et al.^[@b20-kjim-19-2-99-5])^ reported that non-smokers had a weak or insignificant correlation between leukocyte and prevalence of CVD, and an increased leukocyte count was mainly due to smoking in the CVD compared to the control group. There have been some studies on the role of peripheral leukocytes aside from smoking in the pathogenesis of CVD. Some cohort studies have reported that peripheral leukocytes have significant correlation with mortality of CVD, even after adjusting for smoking^[@b13-kjim-19-2-99-5],\ [@b21-kjim-19-2-99-5])^. Also, some prospective studies on patients with a past medical history of myocardial infarction have reported that peripheral leukocytes are a prognostic factor for mortality of coronary heart disease^[@b15-kjim-19-2-99-5],\ [@b16-kjim-19-2-99-5])^. In the present study, there was no significant difference observed in the peripheral leukocyte count between smokers and non-smokers, which was considered to be due to the exclusion of the amount of a patients' past smoking, and females with a relatively lower smoking rate accounted for a higher proportion of the patients than males.

Several hypotheses have been proposed to explain the effect of leukocytes on the pathogenesis and progression of CVD. Overall, with atherosclerotic steps, inflammatory cells were observed within the lesions^[@b22-kjim-19-2-99-5],\ [@b23-kjim-19-2-99-5])^, and monocytes and lymphocytes were present in not only fatty streaks, but also in atheroma, progressing enough to accompany symptoms^[@b22-kjim-19-2-99-5],\ [@b24-kjim-19-2-99-5])^. Cytokines, including TNF-*α* and IL-1, induce atherosclerotic progression by elevating the LDL cholesterol receptors in endothelial cells^[@b25-kjim-19-2-99-5])^. Activation of the inflammatory marker and circulating T cell, including CRP, in unstable angina has been reported^[@b26-kjim-19-2-99-5]--[@b28-kjim-19-2-99-5])^. Stable angina is known to be related with low-grade systemic inflammation^[@b8-kjim-19-2-99-5],\ [@b9-kjim-19-2-99-5])^ and have activated systemic T-cells, proinflammatory cytokines and neutrophils^[@b10-kjim-19-2-99-5],\ [@b11-kjim-19-2-99-5])^.

In the present study, a multiple regression analysis, with a cut-off value of 6,800/mm^3^, the 50 percentile peripheral leukocyte count, showed that an increased peripheral leukocyte count tended to be an independent risk factor for stable angina, but with no statistical significance. However, there was a positive correlation between the Gensini's score and the peripheral leukocyte count, even after adjusting for age, fasting blood sugar, blood pressure and lipid profiles, indicating that an increased peripheral leukocyte count may be related not so much to the incidence of stable angina, as to its severity and progression, which supports the hypothesis that inflammation plays a key role in the pathogenesis of stable angina.

There is a limitation in this cross-sectional study, as it was impossible to determine the causal relationship between the peripheral leukocyte count and the Gensini's score. Therefore, it is considered that a further prospective study will be required to verify the above causal relationship. Also, an inter-group analysis was performed on the basis of the 50 percentile as an arbitrary cut-off value, as the normal variations in the peripheral leukocyte count are unknown in normal adult populations. In this study, the deviation of the peripheral leukocyte count was within the normal range; therefore, more research is needed. The mean age of the patients was 59.8±10.8 years, somewhat high, and the patients unevenly allocated to the control and coronary disease groups. The amount of Patients' past smoking was not considered in the present study. The total cholesterol, triglyceride and LDL cholesterol showed no significant differences between the two groups, and were not risk factors for stable angina, which was considered to be due to the negligence in administration of HMG CoA reductase inhibitor prior to coronary angiography.

In conclusion, an increased peripheral leukocyte count is considered not so much an indicator for the pathogenesis of stable angina, but more as a predictor for disease progression. Furthermore, it is considered that the above correlation will be helpful in screening high-risk stable angina that requires relatively active interventional therapy.

![Relationship between leukocyte count and Gensini's score in 108 patients with stable angina (R^2^= 0.198, *p*=0.015).](kjim-19-2-99-5f1){#f1-kjim-19-2-99-5}

###### 

Clinical Features of the Control and Stable Angina Groups

                                                         Control (n=92)   Stable angina (n=108)
  ------------------------------------------------------ ---------------- -------------------------------------------------------------
  Leukocyte count (1,000/mm^3^)                          6.5±1.5          7.3±1.5[^†^](#tfn3-kjim-19-2-99-5){ref-type="table-fn"}
  Age (years)                                            55.8±11.4        63.1±8.9[^†^](#tfn3-kjim-19-2-99-5){ref-type="table-fn"}
  Male[^†^](#tfn3-kjim-19-2-99-5){ref-type="table-fn"}   49%              47%
  Body mass index (kg/m^2^)                              25.4±3.3         26.2±3.1
  Prevalence of hypertension                             39%              62%[^†^](#tfn3-kjim-19-2-99-5){ref-type="table-fn"}
  Prevalence of diabetes                                 12%              38%[^†^](#tfn3-kjim-19-2-99-5){ref-type="table-fn"}
  Current smoking                                        23%              20%
  Fasting blood sugar (mg/dL)                            100.2±28.6       113.8±52.1[^\*^](#tfn2-kjim-19-2-99-5){ref-type="table-fn"}
  Total cholesterol (mg/dL)                              190.5±39.5       198±47.2
  Triglyceride (mg/dL)                                   146.5±72.9       168±113.8
  LDL (mg/dL)                                            119.8±32.6       121.0±33.8
  HDL (mg/dL)                                            48.2±12.1        44.7±10.4[^\*^](#tfn2-kjim-19-2-99-5){ref-type="table-fn"}
  Systolic blood pressure                                136.6±16.6       138.4±23.1
  Diastolic blood pressure                               87.8±12.7        86.1±13.3

Values are mean±SD or percentage. LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol.

*p*\<0.05

*p*\<0.01

###### 

Multivariate Relationship between Risk Factors and Stable Angina Pectoris (n=200)

                                   OR (95% CI)         *p*-value
  -------------------------------- ------------------- -----------
  Leukocyte count (≥6,800/mm^3^)   1.88 (0.95--3.72)   0.067
  Age (M≥45, F≥55 yrs)             3.62 (1.33--9.87)   0.012
  Presence of diabetes             3.02 (1.29--7.02)   0.010
  Presence of hypertension         1.34 (0.66--2.71)   0.413
  LDL (≥130 mg/dL)                 1.00 (0.99--1.01)   0.973
  HDL (\<40 mg/dL)                 0.97 (0.94--1.00)   0.143

M, male; F, female; yrs, years; LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol.

###### 

Correlation between Gensini's Score and Variables in Patients with Stable Angina (n=108)

                             Coefficient   *p*-value
  -------------------------- ------------- -----------
  Leukocyte count            0.213         0.028
  Age                        0.060         0.121
  Body mass index            0.073         0.486
  Fasting blood sugar        0.307         0.001
  Total cholesterol          0.155         0.114
  Triglyceride               0.002         0.987
  LDL                        0.184         0.076
  HDL                        −0.161        0.121
  Systolic blood pressure    0.112         0.247
  Diastolic blood pressure   0.149         0.124

LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol.
